Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	May 31, 2018
Derivatives [Line Items]
Gain (loss) on foreign currency derivative instruments not designated as hedging instruments	$ (22.6)	$ (36.5)	$ (28.0)	$ (85.8)
Gains (losses) on net investment hedges, net of tax	$ 0.0	0.0	$ 0.0	(25.5)
Minimum
Derivatives [Line Items]
Range of durations of foreign currency forward contracts					1 month	1 month
Maximum
Derivatives [Line Items]
Range of durations of foreign currency forward contracts	15 months		15 months		15 months	12 months
Not designated as hedging instrument
Derivatives [Line Items]
Derivative, Notional Amount	$ 1,340.8		$ 1,340.8			$ 1,238.8
Other current assets | Designated as hedging instrument
Derivatives [Line Items]
Derivative asset, fair value	20.8		20.8			37.9
Other current assets | Not designated as hedging instrument
Derivatives [Line Items]
Derivative asset, fair value	7.0		7.0			25.1
Other noncurrent assets | Designated as hedging instrument
Derivatives [Line Items]
Derivative asset, fair value	3.4		3.4			0.0
Accrued expenses and other | Designated as hedging instrument
Derivatives [Line Items]
Derivative liability, fair value	5.4		5.4			18.4
Accrued expenses and other | Not designated as hedging instrument
Derivatives [Line Items]
Derivative liability, fair value	32.1		32.1			7.6
Foreign exchange contract | Designated as hedging instrument
Derivatives [Line Items]
Derivative, Notional Amount	1,144.1		1,144.1			1,715.5
Foreign Exchange Forward
Derivatives [Line Items]
Unrealized Gain on Derivatives			19.0	29.9
Unrealized Loss on Derivatives			(7.5)	(21.3)
Unrealized Gain (Loss) on Derivatives			11.5	8.6
Net Investment Hedging
Derivatives [Line Items]
Gains (losses) on net investment hedges, net of tax				20.4
Gains (losses) on net investment hedge, excluded component				(3.2)
Revenue | Foreign exchange contract
Derivatives [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(1.7)	77.7	18.3	143.2
Revenue | Cash flows, revenue | Foreign exchange contract
Derivatives [Line Items]
Gain on interest rate swap	(2.1)	6.6	(1.5)	(0.8)
Operating expense | Foreign exchange contract
Derivatives [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	1.2	(0.8)	2.1	(3.5)
Operating expense | Cash flows, operating expenses | Foreign exchange contract
Derivatives [Line Items]
Gain on interest rate swap	0.9	$ (0.1)	(2.0)	(0.4)
Other income (expense) | Net Investment Hedging
Derivatives [Line Items]
Gain (loss) recognized in net income, excluded component				$ (4.6)
Euro | Foreign exchange contract | Designated as hedging instrument
Derivatives [Line Items]
Derivative, Notional Amount	1,006.5		1,006.5			1,495.5
Swiss franc | Foreign exchange contract | Designated as hedging instrument
Derivatives [Line Items]
Derivative, Notional Amount	43.5		43.5			162.8
Japan, Yen | Foreign exchange contract | Designated as hedging instrument
Derivatives [Line Items]
Derivative, Notional Amount	15.4		15.4			57.2
Canadian dollar | Foreign exchange contract | Designated as hedging instrument
Derivatives [Line Items]
Derivative, Notional Amount	$ 78.7		$ 78.7			$ 0.0
Samsung Bioepis
Derivatives [Line Items]
Equity, ownership interest	49.90%		49.90%				49.90%
Percentage of stake in entity								5.00%
Short-term derivative
Derivatives [Line Items]
Range of durations of foreign currency forward contracts	12 months		12 months
Gain/Loss on fair value of foreign currency forward contracts	$ 7.9		$ 7.9